Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

10,627 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,473
Recruiting: 1,285
Ph III recruiting: 130
Growth YoY: +6.4%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,641)

clinicaltrialsPublishedShowing 151–200 of 2,922 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07790913	Obesity Treatment With Phentermine-Topiramate ER in AYA Surviving Leukemia and Lymphoma	not yet recruiting	Phase 2	100	St. Jude Children's Research HospitalOTHER	1	Sep 23, 2026	clinicaltrials
NCT00039676	Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer	active not recruiting	—	1,836	National Cancer Institute (NCI)NIH	1	Sep 22, 2026